drugset / Trial / NCT05894018

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma

NCT05894018

Phase 2 Recruiting 32 enrolled Fujun Zhang
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the effectiveness and safety of radioactive particles in combination with the PARP inhibitor fluzoparib in the treatment of advanced inoperable soft tissue sarcoma.

Timeline

Start
2023-06-29
Primary completion
2028-12-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluzoparib Small molecule 150 mg Oral

Indications